Ealixir Inc (EAXR)

[Neophius]

The issue isn’t the RS. The issue is the 35 million shares being issued after the RS.

In effect, the acquisition of Ealixir is being valued at approx 110 million dollars. The RS used a $3.50 price target multiplied by the 35 million share issuance. In effect, they’re valuing the current shareholders as only 1.7% value due to the nearly 0 value associated with the shell.

It sucks, but that’s life. It makes sense from their perspective, but it certainly leaves a bad taste.